OTC ANALGESIC INDICATION DATA REQUIREMENTS TO BE DISCUSSED
This article was originally published in The Tan Sheet
Executive Summary
OTC ANALGESIC INDICATION DATA REQUIREMENTS TO BE DISCUSSED at a Sept. 8-9 meeting of a subcommittee comprised of members of FDA's Non-proscription Drugs and Arthritis Advisory Committees, the agency announced in a July 11 Federal Register notice.